Ready to invest in stocks?
Discover the best brokers to get started.

Ningbo Menovo Pharm

ISIN CNE100002Y25

 | 

WKN A40PKP

Market cap (in EUR)
857 m
Country
China
Sector
Healthcare
Dividend yield
0.43%
 

Overview

Description

Ningbo Menovo Pharmaceutical Co., Ltd. engages in the research, development, production and sales of specialty APIs and pharmaceutical intermediates. The company provides sales of pharmaceutical raw materials and intermediates, chemical raw materials and products, research and development of pharmaceutical raw materials, preparations, hard capsules and intermediates, self-operated or agency import and export business of various commodities and technologies, but the state Exceptions include goods and technologies that are prohibited or restricted from operation. Its products include pharmaceutical intermediates, active pharmaceutical ingredients, medical formulations, and finished medicines. The company was founded by Cheng Zhi Yao on February 19, 2004 and is headquartered in Ningbo, China.
Show more Show less
Healthcare Healthcare Services Outsourced Development and Manufacturing Services China

Financials

Key metrics

Market capitalisation, EUR 857 m
EPS, EUR 0.04
P/B ratio 2.1
P/E ratio 54.0
Dividend yield 0.43%

Income statement (2025)

Revenue, EUR 185 m
Net income, EUR 13 m
Profit margin 6.82%

What ETF is Ningbo Menovo Pharm in?

There is 1 ETF which contains Ningbo Menovo Pharm.
ETF Weight Investment focus Fund size (in m EUR)
VanEck New China UCITS ETF A 1.12%
Equity
China
Growth
7
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information. (en-IT)